Maximum Dose of Invega Halfyear (Paliperidone Palmitate)
The maximum recommended dose of Invega Halfyear (paliperidone palmitate 6-month formulation) is 1092 mg, administered as a single intramuscular injection every 6 months. 1
Dosing Context and Formulation Differences
It's critical to clarify which paliperidone palmitate formulation you're asking about, as there are three distinct long-acting injectable products with different maximum doses:
1-Month Formulation (Invega Sustenna/PP1M)
- Maximum dose: 234 mg (150 mg eq. paliperidone) administered monthly 1, 2, 3
- Initiation regimen: 234 mg (day 1) followed by 156 mg (day 8), both in deltoid muscle
- Maintenance range: 39-234 mg monthly (recommended 117 mg)
3-Month Formulation (Invega Trinza/PP3M)
- Maximum dose: 546 mg administered every 3 months
- Requires stabilization on PP1M for at least 4 months before switching
6-Month Formulation (Invega Halfyear/PP6M)
- Maximum dose: 1092 mg administered every 6 months 4
- Requires prior stabilization on PP3M or PP1M
- This is the longest-acting antipsychotic formulation currently available
Clinical Considerations
Needle selection matters for optimal absorption: For the 1-month formulation, use a 1-inch 23-gauge needle for patients <90 kg and a 1.5-inch 22-gauge needle for patients ≥90 kg when injecting in the deltoid muscle. 1, 2
Renal impairment requires dose adjustment: In patients with mild renal impairment (CrCl 50-80 mL/min), reduce the maximum dose accordingly. No data exist for severe hepatic impairment. 1, 3
The 6-month formulation showed excellent long-term stability: In a 3-year follow-up study, only 4.1% of patients experienced relapse, with maintained clinical stability on PANSS, CGI-S, and PSP scales. 4 This supports using the maximum dosing interval when patients are stabilized.
Common Pitfalls to Avoid
- Don't confuse formulations: The "Halfyear" designation specifically refers to the 6-month formulation with a 1092 mg maximum dose
- Don't skip the initiation regimen: The 1-month formulation requires specific deltoid loading doses on days 1 and 8—no oral supplementation is needed 2, 3
- Don't ignore the dosing window flexibility: Day 8 doses can be given ±4 days, and monthly maintenance doses ±7 days without clinically significant impact 5